Attovia Therapeutics upsizes IPO proceeds to $332.4M
Attovia Therapeutics upsized IPO proceeds to $332.4 million to extend its cash runway into 2030.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.